Concord Biotech Sets November 4 as Record Date for 1:1 Bonus Share Issue

Concord Biotech has fixed November 4 as the record date for its 1:1 bonus issue, requiring investors to hold shares by November 3 to qualify for the corporate action. On October 30, the company stock closed 1.25 percent higher at ₹1,245.30, despite recording a decline of about 14.28 percent over the preceding year, while delivering 68 percent returns since its initial public offering. Bonus issues involve a company issuing additional free shares to existing shareholders in proportion to their current holdings, utilizing accumulated reserves.

In practice, this corporate action expands the total number of outstanding shares without altering the fundamental market capitalization or underlying business value of the firm, resulting in a proportional adjustment to the per-share trading price. Investors and tax advisors must verify holding dates and monitor subsequent portfolio valuation adjustments following the record date. Track upcoming disclosures and stock price movements closely to assess the precise impact on cost acquisition metrics.

Bottom line: Verify your shareholding status before the November 3 cutoff date to secure your eligible bonus entitlements.